These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12975218)

  • 1. Serotonin syndrome: not a benign toxidrome.
    Garside S; Rosebush PI
    CMAJ; 2003 Sep; 169(6):543. PubMed ID: 12975218
    [No Abstract]   [Full Text] [Related]  

  • 2. Serotonin syndrome: a brief review.
    Birmes P; Coppin D; Schmitt L; Lauque D
    CMAJ; 2003 May; 168(11):1439-42. PubMed ID: 12771076
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding toxidromes: serotonin toxicity: a commentary on Montanes-Rada et al.
    Gillman PK
    J Clin Psychopharmacol; 2005 Dec; 25(6):625-6. PubMed ID: 16282860
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotonin syndrome and other serotonergic disorders.
    Ener RA; Meglathery SB; Van Decker WA; Gallagher RM
    Pain Med; 2003 Mar; 4(1):63-74. PubMed ID: 12873279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The serotonin syndrome.
    Bijl D
    Neth J Med; 2004 Oct; 62(9):309-13. PubMed ID: 15635814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram-induced serotonin syndrome: a case report.
    Tseng WP; Tsai JH; Wu MT; Huang CT; Liu HW
    Kaohsiung J Med Sci; 2005 Jul; 21(7):326-8. PubMed ID: 16089311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant neuroleptic syndrome and serotoninergic syndrome: two cases].
    Bruscas Alijarde MJ; de Benito Cordón L; García Mateos D; Ruiz Clemente M; Hervás Laguna MJ
    Rev Clin Esp; 2007; 207(7):374-5. PubMed ID: 17662207
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome and serotonin syndrome.
    Tormoehlen LM; Rusyniak DE
    Handb Clin Neurol; 2018; 157():663-675. PubMed ID: 30459031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosing neuroleptic malignant syndrome.
    Gruber MP
    Chest; 2004 May; 125(5):1960-1; author reply 1961. PubMed ID: 15136417
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical neuroleptic malignant syndrome or serotonin toxicity associated with atypical antipsychotics?
    Odagaki Y
    Curr Drug Saf; 2009 Jan; 4(1):84-93. PubMed ID: 19149529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sertraline. Adverse effects due to the superposition of serotonic and malignant neuroleptic syndromes].
    López Gastón OD; Wierzbinsky S; López Gastón RS; Resnik S; Pardoménico S; Jorge M
    Medicina (B Aires); 2000; 60(2):241-4. PubMed ID: 10962817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Mixed Presentation of Serotonin Syndrome Versus Neuroleptic Malignant Syndrome in a 12-Year-Old Boy.
    Ott M; Werneke U
    Pediatr Emerg Care; 2019 May; 35(5):e98. PubMed ID: 30964850
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuroleptic Malignant Syndrome or Serotonin Syndrome?
    Nagamine T
    Psychiatr Danub; 2022; 34(3):526-527. PubMed ID: 36256997
    [No Abstract]   [Full Text] [Related]  

  • 14. Recognizing serotonin toxicity in the pediatric emergency department.
    Kant S; Liebelt E
    Pediatr Emerg Care; 2012 Aug; 28(8):817-21; quiz 822-4. PubMed ID: 22863827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant neuroleptic syndrome or serotonergic syndrome].
    Christensen V; Glenthøj BY
    Ugeskr Laeger; 2001 Jan; 163(3):301-2. PubMed ID: 11219110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serotonin syndrome].
    Yamawaki S; Iwamoto Y
    Ryoikibetsu Shokogun Shirizu; 2003; (38):370-3. PubMed ID: 12877005
    [No Abstract]   [Full Text] [Related]  

  • 17. Serotonin syndrome vs neuroleptic malignant syndrome: a contrast of causes, diagnoses, and management.
    Perry PJ; Wilborn CA
    Ann Clin Psychiatry; 2012 May; 24(2):155-62. PubMed ID: 22563571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing between Neuroleptic Malignant Syndrome and Serotonin Syndrome in Polypharmacy: An Overview with a Case Report.
    Debeljak T; Kores Plesničar B
    Psychiatr Danub; 2021; 33(Suppl 4):1227-1229. PubMed ID: 35354191
    [No Abstract]   [Full Text] [Related]  

  • 19. High risk and low prevalence diseases: Serotonin syndrome.
    Spadaro A; Scott KR; Koyfman A; Long B
    Am J Emerg Med; 2022 Nov; 61():90-97. PubMed ID: 36057215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic olanzapine, serotonin receptors, and subsequent serotonin toxicity.
    Monte AA; Waksman JC
    J Clin Psychopharmacol; 2010 Oct; 30(5):628-9. PubMed ID: 20841960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.